As reported by Wang’s group, serum CEA, CA125, and CA153 were found to be higher in metastatic breast cancer patients than breast cancer patients without metastasis.11 Thus, we can only conclude that CEA, CA153, and FER had low diagnostic accuracy for early‐stage breast cancer (stage I‐III). This evidence concerns the gene MUC16 and breast carcinoma.